fda warning bpc-157 not approved safety concerns Patients Using Wellness Peptides Have No Reliable Information About Wh FDA panel backs compounded BPC-157,

The agency flagged three adverse events in its FAERS database tied to compounded injectable BPC-157, including a case in which a patient developed diffuse hyperpigmentation and gingival darkening after using a blended BPC-157/TB-500 product labeled "research purposes only." The safety concern most specific to BPC-157 is its mechanism of action

J.Marin-GarciaJ

79 A metaanalysis including 20 published articles describing the frequency of the e4 form among people in the United States who had been diagnosed with Alzheimer's dementia found that 56% had one copy of the APOEe4 gene, and 11% had two copies of the APOEe4 gene

NNMT Selectivity Appetite Change Powder Stability 5-Amino-1MQ shows high selectivity for NNMT over other methyltransferases, reducing off-target effects

All gastrointestinal disorder events were mild to moderate in severity